From Drug Delivery to Tissue Engineering: Bioengineering and its Impact on Human Health
From Drug Delivery to Tissue Engineering: Bioengineering and its Impact on Human Health
In honor of Robert Langer, Sc.D., and Alian Carpentier, M.D., Ph.D. for their extraordinary contributions to medicine and innovations in bioengineering.
Program
Opening Remarks
Jeffrey S. Flier, MD, Dean of the Faculty of Medicine, Harvard University
Bioengineering and Its Impact on Cardiac Surgery
Alain F. Carpentier, MD, PhD, Chief of Cardiovascular Surgery, Hôptial Européen Georges-Pompidou
Biomaterials and Biotechnology: From the Development of Controlled Drug Delivery Systems to the Foundation of Tissue Engineering
Robert S. Langer Jr., ScD, David H. Koch Institute Professor, Massachusetts Institute of Technology
Infection-Mimicking Polymers as a Cancer Vaccine
David J. Mooney, PhD, School of Applied Engineering and Wyss Institute for Biologically Inspired Engineering, Harvard University
Cancer Nanotechnology to Hepatic Tissue Engineering
Sangeeta Bhatia, MD, PhD, Health Sciences and Technology and Electrical Engineering and Computer Science, Massachusetts Institute of Technology
DNA Nanostructures as Building Blocks for Future Therapeutics
William Shih, PhD, Dana-Farber Cancer Institute, Harvard Medical School, and Wyss Institute for Biologically Inspired Engineering, Harvard University